Formula: | C20H20N2O4 |
Molecular Weight: | 352.39 |
Rotatable Bond Donors: | 5 |
clogP: | 3.73 |
Topological Polar Surface Area: | 86.83 |
Lipinski's RO5: | MW: 352.39 HBA: 6 HBD: 3 RB: 5 LogP: 3.73 |
Rule of Three: | MW: 352.39 HBA: 6 HBD: 3 RB: 5 LogP: 3.73 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC58638788 | 1.0 | ZINC58638788 RDKit 3D 26 28 0 0 0 0 0 0 0 0999 V2000 -4.8472 0.0020 -2.3501 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0365 -0.2385 -0.9600 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.8567 -0.1702 -0.2643 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6397 0.1268 -0.8876 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4256 0.1635 -0.1970 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1419 0.4584 -0.8611 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0388 -0.0428 -0.2891 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3048 0.1610 -0.8331 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5193 -0.3760 -0.2168 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4634 -1.1282 0.9659 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6151 -1.6446 1.5620 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8575 -1.4171 0.9820 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9261 -0.6749 -0.1873 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1387 -0.4459 -0.7640 O 0 0 0 0 0 0 0 0 0 0 0 0 4.7809 -0.1586 -0.7843 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3241 0.9067 -1.9975 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2358 1.4287 -2.6021 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0195 1.2096 -2.0377 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0975 1.7960 -2.6709 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.4713 -0.1381 1.1690 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6655 -0.4395 1.8304 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7187 -0.7264 3.1706 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4249 -0.7402 3.7603 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8704 -0.4350 1.1136 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0090 -0.7735 1.8030 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.0191 0.1945 1.5462 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 1 0 6 7 2 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 2 0 12 13 1 0 13 14 1 0 13 15 2 0 8 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 5 20 2 0 20 21 1 0 21 22 1 0 22 23 1 0 21 24 2 0 24 25 1 0 25 26 1 0 24 3 1 0 18 6 1 0 15 9 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |